Pemigatinib
INCB 54828-302
Phase 3 small_molecule terminated
Quick answer
Pemigatinib for Unresectable Cholangiocarcinoma is a Phase 3 program (small_molecule) at Incyte with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte
- Indication
- Unresectable Cholangiocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated